SPIRONOLACTONE

Product NDC: 63629-1830
Requested package NDC: 63629-1830-2
11-digit product format: 636291830
Labeler code: 63629
Product ID: 63629-1830_e2c30b41-efb4-4443-8a4b-d6bbfc2132a1
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: SPIRONOLACTONE
Dosage form: TABLET
Route: ORAL
Labeler: Bryant Ranch Prepack
Application: ANDA089424
Marketing category: ANDA
Marketing start: 1986-07-23
Marketing end: 2029-02-28
Substance: SPIRONOLACTONE
Active strength: 25 mg/1
Pharmacologic classes: Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]
NDC exclude flag: No
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 1 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Archive	Snapshot	Source SHA-256
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	63629-1830	63629-1830-2	I	Inactivated by FDA		excluded / ndc_excluded.zip	`9bebd1f3094a…`	`5416666fcb17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A089424-001	SPIRONOLACTONE	SPIRONOLACTONE	25MG	TABLET / ORAL	AB	1986-07-23
A089424-002	SPIRONOLACTONE	SPIRONOLACTONE	50MG	TABLET / ORAL	AB	1999-08-11
A089424-003	SPIRONOLACTONE	SPIRONOLACTONE	100MG	TABLET / ORAL	AB	1999-08-11

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A089424-001	AB
A089424-002	AB
A089424-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A089424-001	SPIRONOLACTONE	25MG	TABLET / ORAL	AB	1986-07-23	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A089424-002	SPIRONOLACTONE	50MG	TABLET / ORAL	AB	1999-08-11	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A089424-003	SPIRONOLACTONE	100MG	TABLET / ORAL	AB	1999-08-11	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A089424-001	SPIRONOLACTONE	25MG	TABLET / ORAL	AB	1986-07-23	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A089424-002	SPIRONOLACTONE	50MG	TABLET / ORAL	AB	1999-08-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A089424-003	SPIRONOLACTONE	100MG	TABLET / ORAL	AB	1999-08-11	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A089424-001	SPIRONOLACTONE	25MG	TABLET / ORAL	AB	1986-07-23	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A089424-002	SPIRONOLACTONE	50MG	TABLET / ORAL	AB	1999-08-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A089424-003	SPIRONOLACTONE	100MG	TABLET / ORAL	AB	1999-08-11	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A089424-001	SPIRONOLACTONE	25MG	TABLET / ORAL	AB	1986-07-23	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A089424-002	SPIRONOLACTONE	50MG	TABLET / ORAL	AB	1999-08-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A089424-003	SPIRONOLACTONE	100MG	TABLET / ORAL	AB	1999-08-11	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A089424-001	SPIRONOLACTONE	25MG	TABLET / ORAL	AB	1986-07-23	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A089424-002	SPIRONOLACTONE	50MG	TABLET / ORAL	AB	1999-08-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A089424-003	SPIRONOLACTONE	100MG	TABLET / ORAL	AB	1999-08-11	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A089424-001	SPIRONOLACTONE	25MG	TABLET / ORAL	AB	1986-07-23	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A089424-002	SPIRONOLACTONE	50MG	TABLET / ORAL	AB	1999-08-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A089424-003	SPIRONOLACTONE	100MG	TABLET / ORAL	AB	1999-08-11	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A089424-001	SPIRONOLACTONE	25MG	TABLET / ORAL	AB	1986-07-23	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A089424-002	SPIRONOLACTONE	50MG	TABLET / ORAL	AB	1999-08-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A089424-003	SPIRONOLACTONE	100MG	TABLET / ORAL	AB	1999-08-11	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A089424-001	SPIRONOLACTONE	25MG	TABLET / ORAL	AB	1986-07-23	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A089424-002	SPIRONOLACTONE	50MG	TABLET / ORAL	AB	1999-08-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A089424-003	SPIRONOLACTONE	100MG	TABLET / ORAL	AB	1999-08-11	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A089424-001	SPIRONOLACTONE	25MG	TABLET / ORAL	AB	1986-07-23	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A089424-002	SPIRONOLACTONE	50MG	TABLET / ORAL	AB	1999-08-11	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A089424-003	SPIRONOLACTONE	100MG	TABLET / ORAL	AB	1999-08-11	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A089424-001	SPIRONOLACTONE	25MG	TABLET / ORAL	AB	1986-07-23	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A089424-002	SPIRONOLACTONE	50MG	TABLET / ORAL	AB	1999-08-11	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A089424-003	SPIRONOLACTONE	100MG	TABLET / ORAL	AB	1999-08-11	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A089424-001	SPIRONOLACTONE	25MG	TABLET / ORAL	AB	1986-07-23	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A089424-002	SPIRONOLACTONE	50MG	TABLET / ORAL	AB	1999-08-11	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A089424-003	SPIRONOLACTONE	100MG	TABLET / ORAL	AB	1999-08-11	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A089424-001	SPIRONOLACTONE	25MG	TABLET / ORAL	AB	1986-07-23	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A089424-002	SPIRONOLACTONE	50MG	TABLET / ORAL	AB	1999-08-11	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A089424-003	SPIRONOLACTONE	100MG	TABLET / ORAL	AB	1999-08-11	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A089424-001	SPIRONOLACTONE	25MG	TABLET / ORAL	AB	1986-07-23	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A089424-002	SPIRONOLACTONE	50MG	TABLET / ORAL	AB	1999-08-11	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A089424-003	SPIRONOLACTONE	100MG	TABLET / ORAL	AB	1999-08-11	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A089424-001	SPIRONOLACTONE	25MG	TABLET / ORAL	AB	1986-07-23	`301d65b070ca…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A089424-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A089424-002	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A089424-003	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A089424-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A089424-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A089424-003	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A089424-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A089424-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A089424-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A089424-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A089424-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A089424-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A089424-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A089424-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A089424-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A089424-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A089424-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A089424-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A089424-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A089424-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A089424-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A089424-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A089424-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A089424-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A089424-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A089424-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A089424-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A089424-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A089424-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A089424-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A089424-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A089424-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A089424-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A089424-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A089424-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A089424-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A089424-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A089424-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A089424-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A089424-001	AB	1	`301d65b070ca…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: SPIRONOLACTONE

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
SPIRONOLACTONE	25 mg/1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d335cba1-5b36-51c8-120a-594ec9d05330	Product name	5	20251114
25f5e2cf-3572-477b-994c-aa692751e5a8	Product name	2	20250616
c6f86816-7da6-43ea-8c25-ac9758311cc5	Product name	1	20220118
252e11b6-1a9a-4283-a242-df2c129c496d	Product name	3	20170717
f151007d-265d-9fbe-857d-1d44f1cb76ba	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
63629-1830-1	2020-10-16	These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-1	2020-10-16	These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-2	2020-10-16	These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-2	2020-10-16	These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-3	2020-10-16	These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-3	2020-10-16	These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-4	2020-10-16	These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-4	2020-10-16	These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-5	2020-10-16	These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-5	2020-10-16	These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-6	2020-10-16	These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-6	2020-10-16	These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-1	2020-01-31	These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-1	2020-01-31	These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-2	2020-01-31	These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-2	2020-01-31	These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-3	2020-01-31	These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-3	2020-01-31	These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-4	2020-01-31	These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-4	2020-01-31	These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-5	2020-01-31	These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-5	2020-01-31	These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-6	2020-01-31	These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
63629-1830-6	2020-01-31	These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
63629-1830-1	SPIRONOLACTONE	30 in 1 BOTTLE	TABLET	30	14
63629-1830-2	SPIRONOLACTONE	60 in 1 BOTTLE	TABLET	60	14
63629-1830-3	SPIRONOLACTONE	90 in 1 BOTTLE	TABLET	90	14
63629-1830-4	SPIRONOLACTONE	14 in 1 BOTTLE	TABLET	14	14
63629-1830-5	SPIRONOLACTONE	100 in 1 BOTTLE	TABLET	100	14
63629-1830-6	SPIRONOLACTONE	7 in 1 BOTTLE	TABLET	7	14
63629-1830-7	SPIRONOLACTONE	10 in 1 BOTTLE	TABLET	10	14
63629-1830-8	SPIRONOLACTONE	180 in 1 BOTTLE	TABLET	180	14
63629-1830-9	SPIRONOLACTONE	45 in 1 BOTTLE	TABLET	45	14

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
63629-1830-1	EA - Each	63629-1830	233b145f-3857-4aa7-bc6c-0ae88ededa68	1	2012-07-24
63629-1830-2	EA - Each	63629-1830	a464c793-83dd-4769-9646-4b19d51ccbd1	1	2012-07-24
63629-1830-3	EA - Each	63629-1830	84d6edb6-0bba-4ad8-b17a-e5206808bcc5	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
SPIRONOLACTONE	ACTIVE INGREDIENT	27O7W4T232	SPIRONOLACTONE TABLET [BRYANT RANCH PREPACK]	3
SPIRONOLACTONE	ACTIVE MOIETY	27O7W4T232	SPIRONOLACTONE TABLET [BRYANT RANCH PREPACK]	3
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	SPIRONOLACTONE TABLET [BRYANT RANCH PREPACK]	3
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	SPIRONOLACTONE TABLET [BRYANT RANCH PREPACK]	3
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	SPIRONOLACTONE TABLET [BRYANT RANCH PREPACK]	3
DOCUSATE SODIUM	INACTIVE INGREDIENT	F05Q2T2JA0	SPIRONOLACTONE TABLET [BRYANT RANCH PREPACK]	3
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	SPIRONOLACTONE TABLET [BRYANT RANCH PREPACK]	3
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	SPIRONOLACTONE TABLET [BRYANT RANCH PREPACK]	3
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	SPIRONOLACTONE TABLET [BRYANT RANCH PREPACK]	3
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	SPIRONOLACTONE TABLET [BRYANT RANCH PREPACK]	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63629-1830	SPIRONOLACTONE TABLET [BRYANT RANCH PREPACK]	13	Current NDC, Legacy NDC, 9 package rows	20230406_2efb4720-625f-6616-b6f0-8b13a17c9d7e.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 34 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
SPIRONOLACTONE	SPIRONOLACTONE	Bryant Ranch Prepack	3b60de71-2afa-4922-ba3e-0664c2ae29a0	2026-09-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089424 application number: ANDA089424
SPIRONOLACTONE	SPIRONOLACTONE	Bryant Ranch Prepack	d6138536-cdc1-4459-84ff-9dedc0de1105	2026-09-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089424 application number: ANDA089424
SPIRONOLACTONE	SPIRONOLACTONE	Bryant Ranch Prepack	caf41e17-0461-4667-9eab-62853b945131	2026-09-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089424 application number: ANDA089424
SPIRONOLACTONE	SPIRONOLACTONE	Bryant Ranch Prepack	a6e0bf0e-42d3-41e4-854b-811df3bbaaa9	2026-09-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089424 application number: ANDA089424
SPIRONOLACTONE	SPIRONOLACTONE	Bryant Ranch Prepack	1fe93db1-0012-4ff6-a4e6-04e2d7e9f638	2026-09-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089424 application number: ANDA089424
SPIRONOLACTONE	SPIRONOLACTONE	Bryant Ranch Prepack	1b29888c-09f9-4cd5-9b4c-920bd159a727	2026-09-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089424 application number: ANDA089424
SPIRONOLACTONE	SPIRONOLACTONE	Bryant Ranch Prepack	b98b7780-e310-493a-83bd-bb3d93cf8dde	2026-09-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089424 application number: ANDA089424
SPIRONOLACTONE	SPIRONOLACTONE	Bryant Ranch Prepack	753bbc6f-2e50-49c1-b5bf-18f8411a1e8e	2026-09-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089424 application number: ANDA089424
SPIRONOLACTONE	SPIRONOLACTONE	Bryant Ranch Prepack	0cc23419-e6d5-4036-8011-dc1d2455e0cb	2026-09-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089424 application number: ANDA089424
SPIRONOLACTONE	SPIRONOLACTONE	REMEDYREPACK INC.	7c59e03a-b058-4f6e-b104-0836d9b56392	2026-09-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089424 application number: ANDA089424
SPIRONOLACTONE	SPIRONOLACTONE	Preferred Pharmaceuticals Inc.	3486d831-06b6-4e8f-bd6f-52f7759988f5	2026-08-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089424 application number: ANDA089424
SPIRONOLACTONE	SPIRONOLACTONE	Sun Pharmaceutical Industries, Inc.	c23b6b9b-aec3-48a8-a518-76e4097f6479	2026-07-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089424 application number: ANDA089424
SPIRONOLACTONE	SPIRONOLACTONE	Bryant Ranch Prepack	be4aa233-1555-4972-858e-46343a710558	2026-07-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089424 application number: ANDA089424
SPIRONOLACTONE	SPIRONOLACTONE	Bryant Ranch Prepack	11d06acd-1351-4afd-a16a-f035758e2a27	2026-07-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089424 application number: ANDA089424
SPIRONOLACTONE	SPIRONOLACTONE	Bryant Ranch Prepack	ca194a2a-ed16-40f6-a78c-45c5f3392170	2026-07-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089424 application number: ANDA089424
SPIRONOLACTONE	SPIRONOLACTONE	Bryant Ranch Prepack	ebc4efec-7895-4298-8e75-360bb7992f8d	2026-07-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089424 application number: ANDA089424
SPIRONOLACTONE	SPIRONOLACTONE	Bryant Ranch Prepack	813d199a-9004-4102-8ade-cf877caedafb	2026-05-21	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089424 application number: ANDA089424
SPIRONOLACTONE	SPIRONOLACTONE	Bryant Ranch Prepack	bb1423e8-1517-44c5-98e0-99be24ce269b	2026-05-21	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089424 application number: ANDA089424
SPIRONOLACTONE	SPIRONOLACTONE	Bryant Ranch Prepack	2d0655d7-fda6-40c6-907c-acaba0e19987	2026-05-21	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089424 application number: ANDA089424
SPIRONOLACTONE	SPIRONOLACTONE	Bryant Ranch Prepack	1c31c953-05ce-475a-b93f-80aeb12bde95	2026-05-21	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 089424 application number: ANDA089424

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
27O7W4T232	SPIRONOLACTONE	52-01-7	SPIRONOLACTONE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
313096	spironolactone 25 MG Oral Tablet	PSN	2efb4720-625f-6616-b6f0-8b13a17c9d7e	14
313096	spironolactone 25 MG Oral Tablet	SCD	2efb4720-625f-6616-b6f0-8b13a17c9d7e	14

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
63629-1830-2	63629183002	60 TABLET in 1 BOTTLE (63629-1830-2)	60 tablet	2010-02-12	2029-02-28	No	No	Current